7. Mid‐term results (6 months after initiation of treatment) for QoL (all risk groups combined).

Trial	time point of measurement (in months)	Intervention (N analysed)	Intervention post mean score (SD)	Comparator (N analysed)	Comparator post mean score (SD)
Scale: FKSI‐DRS (score range 0‐36; higher scores represent better QoL)
NCT01108445	6.9	EVE (N=13)	29.8 (3.76)	SUN (N = 19)	27.6 (4.37)
NCT00098657/NCT00083889	6.4	SUN (N=242)	29.43 (4.280)	IFN (N = 109)	28.37 (4.726)
NCT00920816	6.4	AXI (N=131)	28.557 (4.308)	SOR (N = 60)	30.296 (3.890)
Scale: EQ‐5D‐VAS (score range 0‐100; higher scores represent better QoL)
NCT00098657/NCT00083889	6.4	SUN (N=240)	75.13 (16.771)	IFN (N=104)	72.57 (16.007)
NCT00920816	6.4	AXI (N=131)	71.031 (19.081)	SOR (N = 60)	73.183 (16.674)
Scale: FACT‐G (score range 0‐108; higher scores represent better QoL)
NCT00098657/NCT00083889	6.4	SUN (N=241)	82.23 (15.124)	IFN (N = 106)	80.60 (15.527)
Scale: FACIT‐F (score range 0‐52; higher scores represent better QoL)
NCT00720941	6.5	PAZ (N=230)	38.8 (9.55)	SUN (N = 226)	36.2 (10.26)

Comparisons including SUN are bold. The scales are listed in no particular order.